Aberrant hypermethylation of ID4 gene promoter region increases risk of lymph node metastasis in T1 breast cancer

Oncogene

Volumn 24, Issue 29, 2005, Pages 4721-4727

  Umetani, Naoyuki ^a   Mori, Takuji ^a   Koyanagi, Kazuo ^a   Shinozaki, Masaru ^a   Kim, Joseph ^a   Giuliano, Armando E ^a   Hoon, Dave S B ^a  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

Author keywords

Breast cancer; Hypermethylation; ID4; Lymph node metastasis

Indexed keywords

BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; DNA; HELIX LOOP HELIX PROTEIN; MESSENGER RNA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL CULTURE; CANCER INHIBITION; CPG ISLAND; DNA METHYLATION; EPIGENETICS; GENE; GENE ACTIVATION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; ID4 GENE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METHYLATION SPECIFIC POLYMERASE CHAIN REACTION; MULTIGENE FAMILY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; DNA METHYLATION; DNA-BINDING PROTEINS; FEMALE; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEINS; NEOPLASM STAGING; PROMOTER REGIONS (GENETICS); RISK FACTORS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 22744444015     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208538     Document Type: Article

References (36)

1. Barth A, Craig PH and Silverstein MJ. (1997). Cancer, 79, 1918-1922.
2. Beger C, Pierce LN, Kruger M, Marcusson EG, Robbins JM, Welcsh P, Welch PJ, Welte K, King MC, Barber JR and Wong-Staal F. (2001). Proc. Natl. Acad. Sci. USA, 98, 130-135.
3. Benezra R, Rafii S and Lyden D. (2001). Oncogene, 20, 8334-8341.
4. Brenin DR, Manasseh DM, El-Tamer M, Troxel A, Schnabel F, Ditkoff BA and Kinne D. (2001). Ann. Surg. Oncol., 8, 432-437.
5. Carter BA, Jensen RA, Simpson JF and Page DL. (2000). Am. J. Clin. Pathol., 113, 259-265.
6. Carter CL, Allen C and Henson DE. (1989). Cancer, 63, 181-187.
7. Chan AS, Tsui WY, Chen X, Chu KM, Chan TL, Li R, So S, Yuen ST and Leung SY. (2003). Oncogene, 22, 6946-6953.
8. Esteller M and Herman JG. (2002). J. Pathol., 196, 1-7.
9. Fisher ER, Anderson S, Redmond C and Fisher B. (1993). Cancer, 71, 2507-2514.
10. Fisher ER, Fisher B, Sass R and Wickerham L. (1984). Cancer, 54, 3002-3011.
11. Fitzgibbons PL, Page DL, Weaver D, Thor AD, Allred DC, Clark GM, Ruby SG, O'Malley F, Simpson JF, Connolly JL, Hayes DF, Edge SB, Lichter A and Schnitt SJ. (2000). Arch. Pathol. Lab. Med., 124, 966-978.
12. Herman JG and Baylin SB. (2003). N. Engl. J. Med., 349, 2042-2054.
13. Herman JG, Graff JR, Myohanen S, Nelkin BD and Baylin SB. (1996). Proc. Natl. Acad. Sci. USA, 93, 9821-9826.
14. Holland PA, Walls J, Boggis CR, Knox F, Baildam AD and Hundred NJ. (1996). Br. J. Cancer, 74, 1643-1646.
15. Hoon DS, Spugnardi M, Kuo C, Huang SK, Morton DL and Taback B. (2004). Oncogene, 23, 4014-4022.
16. Itahana Y, Singh J, Sumida T, Coppe JP, Parrinello S, Bennington JL and Desprez PY. (2003). Cancer Res., 63, 7098-7105.
17. Jen Y, Manova K and Benezra R. (1996). Dev. Dyn., 207, 235-252.
18. Jen Y, Manova K and Benezra R. (1997). Dev. Dyn., 208, 92-106.
19. Jones PA. (1996). Cancer Res., 56, 2463-2467.
20. Jones PA. (1999). Trends Genet., 15, 34-37.
21. Kee Y and Bronner-Fraser M. (2001). Mech. Dev., 109, 341-345.
22. Lin CQ, Singh J, Murata K, Itahana Y, Parrinello S, Liang SH, Gillett CE, Campisi J and Desprez PY. (2000). Cancer Res., 60, 1332-1340.
23. Massari ME and Murre C. (2000). Mol. Cell. Biol., 20, 429-440.
24. Moore KH, Thaler HT, Tan LK, Borgen PI and Cody III HS. (2004). Cancer, 100, 929-934.
25. Pagliuca A, Bartoli PC, Saccone S, Della Valle G and Lania L. (1995). Genomics, 27, 200-203.
26. Rivera R and Murre C. (2001). Oncogene, 20, 8308-8316.
27. Schoppmann SF, Schindl M, Bayer G, Aumayr K, Dienes J, Horvat R, Rudas M, Gnant M, Jakesz R and Birner P. (2003). Int. J. Cancer, 104, 677-682.
28. Shan L, Yu M, Qiu C and Snyderwine EG. (2003). Am. J. Pathol., 163, 2495-2502.
29. Singh J, Murata K, Itahana Y and Desprez PY. (2002). Oncogene, 21, 1812-1822.
30. Spugnardi M, Tommasi S, Dammann R, Pfeifer GP and Hoon DS. (2003). Cancer Res., 63, 1639-1643.
31. Takeuchi H, Kuo C, Morton DL, Wang HJ and Hoon DS. (2003). Cancer Res., 63, 441-448.
32. Toyota M and Issa JP. (1999). Semin. Cancer Biol., 9, 349-357.
33. Umetani N, Fujimoto A, Takeuchi H, Shinozaki M, Bilchik AJ and Hoon DS. (2004a). Oncogene, 23, 8292-8300.
34. Umetani N, Takeuchi H, Fujimoto A, Shinozaki M, Bilchik AJ and Hoon DS. (2004b). Clin. Cancer Res., 10, 7475-7483.
35. Welcsh PL, Lee MK, Gonzalez-Hernandez RM, Black DJ, Mahadevappa M, Swisher EM, Warrington JA and King MC. (2002). Proc. Natl. Acad. Sci. USA, 99, 7560-7565.
36. Zebedee Z and Hara E. (2001). Oncogene, 20, 8317-8325.